InvestSMART

The article you are trying to access does not exist, however, here are some articles you may be interested in.

NeuroScientific Biopharmaceuticals Ltd (ASX: NSB) - Announcements

Current share price for NSB : $0.064 0.001 (1.59%)+

ASX company news and announcements for NeuroScientific Biopharmaceuticals Ltd (NSB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All NeuroScientific Biopharmaceuticals Ltd (NSB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than NeuroScientific Biopharmaceuticals Ltd (NSB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for NeuroScientific Biopharmaceuticals Ltd (NSB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$25 Further information on changes to Board 14 Nov 2023 12:29PM $0.055 $0.064 risen by 16.36%
$25 Changes to Board 13 Nov 2023 8:20AM $0.056 $0.064 risen by 14.29%
$25 Investor Update Presentation 31 Oct 2023 1:55PM $0.060 $0.064 risen by 6.67%
$25 Investor Update Webinar 30 Oct 2023 3:15PM $0.061 $0.064 risen by 4.92%
$25 Quarterly Activities/Appendix 4C Cash Flow Report 30 Oct 2023 3:11PM $0.061 $0.064 risen by 4.92%
$25 Notification regarding unquoted securities - NSB 24 Oct 2023 6:21PM $0.060 $0.064 risen by 6.67%
$25 Proposed issue of securities - NSB 24 Oct 2023 3:09PM $0.060 $0.064 risen by 6.67%
$25 Notice of Annual General Meeting/Proxy Form 24 Oct 2023 1:30PM $0.060 $0.064 risen by 6.67%
$25 Proposed issue of securities - NSB 23 Oct 2023 1:20PM $0.070 $0.064 fallen by 8.57%
$25 Appointment of Director - Dr Linda Friedland 18 Oct 2023 5:18PM $0.060 $0.064 risen by 6.67%
$25 Date of AGM & Closing Date for Director Nominations 28 Sep 2023 4:24PM $0.075 $0.064 fallen by 14.67%
$25 Appointment of CEO 31 Aug 2023 1:53PM $0.090 $0.064 fallen by 28.89%
$25 Appendix 4G 30 Aug 2023 12:50PM $0.090 $0.064 fallen by 28.89%
$25 Corporate Governance Statement 30 Aug 2023 12:48PM $0.090 $0.064 fallen by 28.89%
$25 2023 Annual Report and Appendix 4E 25 Aug 2023 3:30PM $0.090 $0.064 fallen by 28.89%
$25 Expiry of Performance Shares 1 Aug 2023 1:31PM $0.099 $0.064 fallen by 35.35%
$25 Notification of cessation of securities - NSB 1 Aug 2023 1:29PM $0.099 $0.064 fallen by 35.35%
$25 Issuance of Shares 1 Aug 2023 1:25PM $0.099 $0.064 fallen by 35.35%
$25 Application for quotation of securities - NSB 1 Aug 2023 1:23PM $0.099 $0.064 fallen by 35.35%
$25 Quarterly Activities/Appendix 4C Cash Flow Report 28 Jul 2023 10:04AM $0.089 $0.064 fallen by 28.09%
$25 Proposed issue of securities - NSB 27 Jul 2023 11:23AM $0.089 $0.064 fallen by 28.09%
$25 Change of Director's Interest Notice - Quantrill 6 Jul 2023 4:14PM $0.105 $0.064 fallen by 39.05%
$25 Change of Director's Interest Notice - Rennie 7 Jun 2023 8:22AM $0.090 $0.064 fallen by 28.89%
$25 Change of Director's Interest Notice - Uvarov 25 May 2023 3:30PM $0.100 $0.064 fallen by 36%
$25 Change of Director's Interest Notice - Rennie 25 May 2023 3:07PM $0.100 $0.064 fallen by 36%

101 - 125 of 407 results

Page 5 of 17

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.